A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus.
Saved in:
| Title: | A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus. |
|---|---|
| Authors: | Young A; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia., Kolekar S; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Mendoza CA; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Jaberolansar N; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia., Modhiran N; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia., Webb T; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., McCuaig R; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Kommajosyula V; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Tardiota N; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Dy Q; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Amarilla AA; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia., Dalrymple RL; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia., Gillard M; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia., Dutton JL; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.; Vicebio Pty Ltd, Louvain-la-Neuve, Belgium., Magdalena J; Vicebio Pty Ltd, Louvain-la-Neuve, Belgium., Vandendriessche F; Vicebio Pty Ltd, Louvain-la-Neuve, Belgium., Smal J; Vicebio Pty Ltd, Louvain-la-Neuve, Belgium., Young PR; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, Queensland, Australia., Watterson D; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, Queensland, Australia., Hanon EJ; Vicebio Pty Ltd, Louvain-la-Neuve, Belgium., Chappell KJ; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.; Vicebio Pty Ltd, Louvain-la-Neuve, Belgium.; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, Queensland, Australia. |
| Source: | PLoS pathogens [PLoS Pathog] 2025 Jul 17; Vol. 21 (7), pp. e1013312. Date of Electronic Publication: 2025 Jul 17 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553-7374 |
|---|---|
| DOI: | 10.1371/journal.ppat.1013312 |
